Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,979,159
+$1,522,874 QoQ
Shares Held
4,985
+2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.80%
of 13F equity value
Holder Rank
#1,578
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Asset Advisory Services LLC holds $29,712,872 across 11 Drug Manufacturers - General names. LLY ranks #2 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,233 | $6,662,395 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
4,985 | $5,979,159 | |
| 3 | ABBV |
AbbVie Inc.
|
22,814 | $5,740,914 | |
| 4 | PFE |
Pfizer Inc
|
138,613 | $3,337,801 | |
| 5 | MRK |
Merck & Co., Inc.
|
23,955 | $3,078,217 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
46,813 | $2,697,365 | |
| 7 | AMGN |
Amgen Inc
|
1,448 | $524,349 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,064 | $513,445 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,979,159 | 4,985 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,456,285 | 4,845 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $6,368,554 | 5,926 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $4,906,090 | 6,430 | Shares | Sole | 2025-10-02 | |
| 2025-06-30 | $4,766,825 | 6,115 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $4,887,735 | 5,918 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $4,451,352 | 5,766 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $4,637,895 | 5,235 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $4,665,423 | 5,153 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $4,292,783 | 5,518 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $3,101,134 | 5,320 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $2,963,346 | 5,517 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,462,145 | 5,250 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $1,713,322 | 4,989 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,689,083 | 4,617 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $1,226,466 | 3,793 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,044,020 | 3,220 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $910,656 | 3,180 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $773,416 | 2,800 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $626,145 | 2,710 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $621,999 | 2,710 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $541,404 | 2,898 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $490,986 | 2,908 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $431,922 | 2,918 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $471,853 | 2,874 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $384,948 | 2,775 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||